Islands Dispute Hits Japan Device Sales In China While Pharma Less Affected
This article was originally published in PharmAsia News
Executive Summary
Both Japanese and Chinese device makers have reported lower sales and profits linked to a rift over disputed islands, potentially signaling a lengthy period of strained trade ties.